Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pernilla Stridh

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Neuroinflammation|June 3, 2026
Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progressionYuan Jiang, Jinyu Xiao, Ingrid Kockum, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
International Journal of Epidemiology|January 11, 2023
Association between exposure to combustion-related air pollution and multiple sclerosis riskAnna Karin Hedström, David Segersson, Jan Hillert, et al.
Journal of Neurology|December 23, 2018
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide studyJie Song, Helga Westerlind, Kyla A McKay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2022
Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort studyKelsi A Smith, Fredrik Piehl, Tomas Olsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2025
Multiomics integration prioritizes potential drug targets for multiple sclerosisYuan Jiang, Qianwen Liu, Pernilla Stridh, et al.
Journal of Autoimmunity|July 31, 2024
Shared aetiology underlying multiple sclerosis and other immune mediated inflammatory diseases: Swedish familial co-aggregation and large-scale genetic correlation analysesQianwen Liu, Yuan Jiang, Thomas Frisell, et al.
Brain Injury|November 7, 2002
Brain injury: quality of life's greatest challengePennie S Seibert, D Peter Reedy, Joanne Hash, et al.
Arthritis Research & Therapy|January 9, 2008
Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritisTherese Ostberg, Heidi Wähämaa, Karin Palmblad, et al.
Journal of Neuroinflammation|October 30, 2015
MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulatedSevasti Flytzani, Andre Ortlieb Guerreiro-Cacais, Marie N'diaye, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Neuroinflammation|June 3, 2026
Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progressionYuan Jiang, Jinyu Xiao, Ingrid Kockum, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2019
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort studyLoes Crielaard, Andrius Kavaliunas, Ryan Ramanujam, et al.
International Journal of Epidemiology|January 11, 2023
Association between exposure to combustion-related air pollution and multiple sclerosis riskAnna Karin Hedström, David Segersson, Jan Hillert, et al.
Journal of Neurology|December 23, 2018
Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide studyJie Song, Helga Westerlind, Kyla A McKay, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2022
Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort studyKelsi A Smith, Fredrik Piehl, Tomas Olsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2025
Multiomics integration prioritizes potential drug targets for multiple sclerosisYuan Jiang, Qianwen Liu, Pernilla Stridh, et al.
Journal of Autoimmunity|July 31, 2024
Shared aetiology underlying multiple sclerosis and other immune mediated inflammatory diseases: Swedish familial co-aggregation and large-scale genetic correlation analysesQianwen Liu, Yuan Jiang, Thomas Frisell, et al.
Brain Injury|November 7, 2002
Brain injury: quality of life's greatest challengePennie S Seibert, D Peter Reedy, Joanne Hash, et al.
Arthritis Research & Therapy|January 9, 2008
Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritisTherese Ostberg, Heidi Wähämaa, Karin Palmblad, et al.
Journal of Neuroinflammation|October 30, 2015
MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulatedSevasti Flytzani, Andre Ortlieb Guerreiro-Cacais, Marie N'diaye, et al.
Pageof 7